Director Gavin Molinelli receives 6,237 ACTG shares for Q1 2026 fees

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.

ACACIA RESEARCH CORP director Gavin Molinelli received a stock grant as compensation. On March 31, 2026, he was awarded 6,237 shares of common stock at $4.81 per share in lieu of cash for his Q1 2026 director fees. After this grant, he directly holds 174,476 shares of Acacia Research common stock. This is a compensatory share award, not an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Molinelli Gavin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.001	6,237	$4.81	$30K

Holdings After Transaction: Common Stock, par value $0.001 — 174,476 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Shares granted: 6,237 shares Grant price: $4.81 per share Total holdings after grant: 174,476 shares

3 metrics

Shares granted 6,237 shares Stock grant on March 31, 2026 for Q1 2026 director fees

Grant price $4.81 per share Value assigned to the 6,237-share compensation grant

Total holdings after grant 174,476 shares Director Gavin Molinelli’s direct common stock holdings after the transaction

Key Terms

Grant, award, or other acquisition, in lieu of cash, director fees

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

in lieu of cash financial

"Grant of shares of Common Stock in lieu of cash for Q1 2026 director fees"

director fees financial

"in lieu of cash for Q1 2026 director fees"

Form 4 Insider Transactions: What Each Field Means →

04/01/2026 - 09:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Molinelli Gavin

(Last)

(First)

(Middle)

777 THIRD AVENUE, 18TH FLOOR

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACACIA RESEARCH CORP [ ACTG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.001	03/31/2026		A		6,237⁽¹⁾	A	$4.81	174,476	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Grant of shares of Common Stock in lieu of cash for Q1 2026 director fees.

	/s/ Gavin T. Molinelli	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did ACTG director Gavin Molinelli report?

Director Gavin Molinelli reported receiving a grant of 6,237 shares of ACACIA RESEARCH CORP common stock. The shares were issued as compensation, not bought on the market, reflecting payment of his Q1 2026 director fees in stock rather than cash.

At what price were Gavin Molinelli’s ACTG shares granted?

The 6,237 ACACIA RESEARCH CORP shares granted to Gavin Molinelli were valued at $4.81 per share. This value reflects the grant price used for the stock award issued in lieu of cash compensation for his Q1 2026 director fees.

How many ACTG shares does Gavin Molinelli hold after this grant?

Following the grant, Gavin Molinelli directly holds 174,476 shares of ACACIA RESEARCH CORP common stock. This total includes the 6,237 shares awarded on March 31, 2026 as stock compensation for his Q1 2026 director service.

Was Gavin Molinelli’s ACTG Form 4 transaction a market purchase or sale?

The Form 4 transaction is a stock grant, not a market trade. ACACIA RESEARCH CORP issued 6,237 shares to Gavin Molinelli in lieu of cash for Q1 2026 director fees, so no open-market buying or selling occurred in this transaction.

Why did ACACIA RESEARCH CORP grant shares to Gavin Molinelli for Q1 2026?

ACACIA RESEARCH CORP granted shares to Gavin Molinelli as payment for his Q1 2026 director fees. Instead of receiving cash, he was compensated with 6,237 shares of common stock, aligning part of his compensation with the company’s equity.